Charity Scripture - 01 Dec 2021 Form 4 Insider Report for BELLICUM PHARMACEUTICALS, INC

Reporting relationship: Chief Development Officer
Issuer ticker: N/A
Reported as of: 01 Dec 2021
Net transaction value: +$259,500
SEC form: 4
Accepted by SEC: 02 Dec 2021, 14:23:39 UTC
Next SEC filing: 16 Aug 2022
Source filing: View source filing
Reporting owner signature: Charity Scripture

Key filing fact

Charity Scripture filed Form 4 for BELLICUM PHARMACEUTICALS, INC on 02 Dec 2021.

Key facts

This page summarizes Charity Scripture's Form 4 filing for BELLICUM PHARMACEUTICALS, INC.
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Dec 2021, 14:23.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$259,500.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BLCM transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $259,500
Shares: +150,000
Change %
Price: $1.73
Shares after: 150,000
Date: 01 Dec 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 150,000
Exercise price: $1.73
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

50% of the shares subject to the stock option vest and become exercisable on December 1, 2022, and the remaining shares subject to the stock option vest and become exercisable in 12 equal monthly installments thereafter.